Murray B Stein MD, MPH, FRCPC is Distinguished Professor of Psychiatry and Public Health, and Vice Chair for Clinical Research in Psychiatry at the University of California San Diego (UCSD). He is also a Staff Psychiatrist at the VA San Diego Healthcare System. Dr. Stein graduated from the University of Manitoba and completed his residency and post-residency fellowship at the University of Toronto and at the National Institute of Mental Health in Bethesda, Maryland, USA. He subsequently completed a Master of Public Health degree at the Johns Hopkins University Bloomberg School of Public Health in Baltimore, MD.
Dr. Stein’s research interests include the epidemiology, neurobiology, and treatment of anxiety and trauma-related disorders especially social anxiety disorder, panic disorder, and posttraumatic stress disorder. He has written or co-written over 700 peer-reviewed scientific articles on these topics, including in journals such as JAMA, New England Journal of Medicine, Nature Genetics, Nature Neuroscience, The Lancet, American Journal of Psychiatry, Biological Psychiatry, and JAMA Psychiatry. His federally funded research has included studies of interventions for anxiety disorders in primary care, pharmacological approaches to treatment-resistant anxiety disorders, and functional neuroimaging research in anxiety and trauma-related disorders. He is Co-Principal Investigator (with Robert Ursano MD) of Army STARRS, an NIMH-funded project (2009-2015) investigating risk factors for suicide, PTSD and other deployment-related disorders; this project is now in a longitudinal follow-up phase as STARRS-LS (2019-2023). He is an Executive Committee member for the multi-center TRACK-TBI Study (PI: Geoff Manley MD, PhD at UCSF). He is Co-PI with Kerry Ressler MD PhD of a DoD-funded multi-site trial of the angiotensin receptor antagonist losartan for PTSD (2015-2021). He is also Co-PI (with Joel Gelernter MD) of a VA Merit Grant on the genomics of PTSD and related traits (2019-2023), in conjunction with the VA Million Veteran Program.
Dr. Stein is a member of the Scientific Advisory Board of the Anxiety and Depression Association of American (ADAA), and a Fellow of the American College of Neuropsychopharmacology (ACNP). Dr. Stein is a past Scientific Chair of the NIMH Interventions in Mood and Anxiety (ITMA) Review Group (2006-2009), and was a member of the DSM-5 Anxiety, Obsessive-Compulsive Spectrum, Posttraumatic, and Dissociative Disorders Work Group (2009-2013). He is a past member of the National Academy of Medicine Board on the Health of Select Populations (2012-2015) and the National Academy of Medicine Committee to Review NASA's Evidence Reports on Human Health Risks (2016). He is a past member of the Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee (PDAC) (2011-2016).
Dr. Stein is Co-Editor-in-Chief for UpToDate in Psychiatry, Editor-in-Chief for the journal Depression and Anxiety, and Deputy Editor for the journal Biological Psychiatry.